
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
AZN | London | GBP | Real-time | |
3LAZ | London | GBP | Real-time | |
3SAZ | London | GBP | Real-time | |
AZNl | BATS Europe | GBP | Delayed | |
AZNs | BATS Europe | SEK | Delayed | |
AZN | NASDAQ | USD | Real-time | |
AZNCF | OTC Markets | USD | Delayed | |
AZNN | Mexico | MXN | Delayed | |
AZN | Stockholm | SEK | Real-time | |
AZN | Frankfurt | EUR | Delayed | |
AZN | TradeGate | EUR | Delayed | |
AZN | Xetra | EUR | Delayed | |
AZNPy | Frankfurt | EUR | Delayed | |
AZN | Buenos Aires | ARS | Delayed |
Investing.com - AstraZeneca (NASDAQ:AZN) reported on Friday second quarter earnings that beat analysts' forecasts and revenue that topped expectations. AstraZeneca announced earnings per share of...
FRANKFURT (Reuters) - Long-serving AstraZeneca (NASDAQ:AZN) boss Pascal Soriot said on Friday he expects to work with the new chairman-designate of the London-listed drugmaker, who will take over in...
By Natalie Grover and Ludwig Burger (Reuters) -AstraZeneca said it expected prescriptions of its COVID therapy to drive sales growth of more than 20% this year, as company reported second-quarter...
AstraZeneca Plc (NASDAQ: NASDAQ:AZN) Q2 profits fell sharply on ballooning costs linked to its Alexion (NASDAQ:ALXN) takeover. The net profit was down 68% Y/Y (75% on constant currency) to $247...
Investing.com - AstraZeneca (NASDAQ:AZN) ADR reported on Friday second quarter earnings that beat analysts' forecasts and revenue that topped expectations. AstraZeneca ADR announced earnings per...
AstraZeneca PLC (LSE:NASDAQ:AZN) followed its smaller rival GSK PLC (LSE:GSK, NYSE:GSK) by upgrading guidance for the full year after a bumper first half which exceeded expectations. The key driver...
By Liz Moyer Investing.com -- Stocks notched a two-day rally as investors believe the Federal Reserve could slow the pace of interest rate increases after new data showed the economy slowed in the...
Merck & Co Inc (NYSE: MRK) will stop for futility the Phase 3 LYNK-003 trial of Lynparza with or without bevacizumab for unresectable or metastatic colorectal cancer who have not progressed...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Tuesday, July 5th. Please refresh for updates. Tesla (NASDAQ:TSLA) stock fell 1.4% after the electric car manufacturer delivered...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review